In the first head-to-head comparison of two devices intended to protect against stroke in patients undergoing transcatheter ...
The use of contemporary hormonal contraception is associated with a significantly increased relative risk for ischemic stroke and, in some cases, myocardial infarction (MI), a new real-world study ...
Always call 911, as fact action can save and improve recovery.
Boehringer Ingelheim and the Lower Franconian biotech company EMFRET Analytics have signed a cooperation and license agreement for the preclinical development program of the GPVI‑blocking antibody ...
A clinical trial led by University of Auckland researchers found that high-intensity therapy for patients begun within two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results